Investing.com - Bio-Techne (NASDAQ: TECH) reported first quarter EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $303.4M versus the consensus estimate of $292.91M.
Bio-Techne's stock price closed at $63.21. It is down -4.20% in the last 3 months and down -8.55% in the last 12 months.
Bio-Techne saw 0 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Bio-Techne's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Techne's Financial Health score is "great performance".
Check out Bio-Techne's recent earnings performance, and Bio-Techne's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar